High‐dose methylphenidate vs placebo
Total number of adverse events · Children aged 6 to 18 years with ASD
2 findings from 1 review
- Methylphenidate for children and adolescents with autism spectrum disorder 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 108 participantsGRADE not reported
- Methylphenidate for children and adolescents with autism spectrum disorder 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 79 participantsGRADE not reported